Several types of antibodies targeting different regions of the YGL199C protein are available for research purposes:
Each monoclonal combination consists of multiple individual monoclonal antibodies targeting synthetic peptide antigens from the corresponding region of the YGL199C protein . The polyclonal antibody is antigen-affinity purified and stored in a buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative .
YGL199C antibodies have been validated primarily for the following applications:
Enzyme-Linked Immunosorbent Assay (ELISA): Both monoclonal and polyclonal antibodies show high ELISA titers, with monoclonal combinations demonstrating titers of approximately 10,000, corresponding to detection of approximately 1 ng of target protein .
Western Blotting (WB): The antibodies can be used for detection of YGL199C protein in yeast lysates via western blotting .
For other potential applications such as immunoprecipitation, immunohistochemistry, or flow cytometry, researchers should conduct validation experiments to confirm suitability, as these applications have not been explicitly verified in the available literature for YGL199C antibodies.
When designing experiments with YGL199C antibodies, the following controls are essential to ensure reliable and interpretable results:
Unstained cells: Include a sample without any antibody to establish baseline autofluorescence or background signal .
Negative cells: If available, include cells known not to express YGL199C to control for antibody specificity .
Isotype control: Use an antibody of the same class as your YGL199C antibody but with specificity for an irrelevant antigen not present in your samples. This controls for non-specific binding, particularly through Fc receptors .
Secondary antibody control: For indirect detection methods, include samples treated only with the labeled secondary antibody to assess non-specific binding of the secondary antibody .
Blocking controls: Evaluate the effectiveness of your blocking reagents by comparing blocked versus unblocked samples .
When working specifically with yeast cells, it's important to optimize cell preparation protocols to minimize autofluorescence, which can be particularly high in yeast due to their cell wall composition and metabolic state.
Optimization of YGL199C antibody concentration for Western blotting requires a systematic titration approach:
Initial titration: Start with a range of dilutions (e.g., 1:500, 1:1000, 1:2000, 1:5000) based on the manufacturer's recommendation.
Sample preparation: Include both positive controls (yeast strains known to express YGL199C) and negative controls (deletion strains lacking YGL199C if available).
Optimization table: Document results in a structured format:
| Antibody Dilution | Signal Intensity | Background | Signal-to-Noise Ratio | Notes |
|---|---|---|---|---|
| 1:500 | ||||
| 1:1000 | ||||
| 1:2000 | ||||
| 1:5000 |
Blocking optimization: Test different blocking agents (BSA, non-fat milk, commercial blockers) to determine which provides the best signal-to-noise ratio for YGL199C detection.
Incubation conditions: Evaluate both room temperature and 4°C incubations with varying durations to identify optimal binding conditions.
For monoclonal antibody combinations targeting YGL199C, begin with concentrations that correspond to the reported ELISA titers (approximately 1 ng detection sensitivity) and adjust based on empirical results.
Non-specific binding is a common challenge when working with antibodies against yeast proteins. Consider the following strategies to improve specificity:
Optimize blocking: Use 10% normal serum from the same host species as your labeled secondary antibody. Ensure the normal serum is NOT from the same host species as your primary antibody to avoid non-specific signals .
Pre-adsorption: For polyclonal antibodies, pre-adsorb against yeast lysates prepared from YGL199C deletion strains to remove antibodies that bind to other yeast proteins.
Cell preparation: Ensure high cell viability (>90%) before staining, as dead cells can contribute to high background scatter and false positive staining .
Buffer optimization: Include 0.1% sodium azide in PBS to prevent internalization of membrane antigens, and perform all steps on ice .
Antibody validation: Consider using epitope tagging approaches to validate antibody specificity, by expressing YGL199C with a known epitope tag and confirming co-localization of your YGL199C antibody with an antibody against the tag.
While not specifically documented for YGL199C antibodies, single-cell analysis techniques have been successfully applied to yeast proteins using similar antibodies. To adapt these methods for YGL199C:
Cell wall considerations: Yeast cells require special preparation due to their rigid cell wall. For intracellular proteins like YGL199C, permeabilization protocols must be optimized using agents like zymolyase or lyticase followed by detergent treatment.
Single-cell isolation: Fluorescence-activated cell sorting (FACS) can be used to isolate individual yeast cells based on surface marker expression or other characteristics .
RT-PCR amplification: For correlating antibody binding with gene expression, single-cell RT-PCR can be performed using protocols similar to those described for human B cells , adapted for yeast:
Perform reverse transcription in 14 μl reactions using random hexamer primers
Use nested PCR to amplify specific transcripts
Consider combining antibody staining data with transcript analysis
Controls: Include unstained cells, isotype controls, and cells from YGL199C deletion strains to establish gating strategies and confirm antibody specificity.
The combination of antibody-based protein detection with single-cell transcriptomics can provide valuable insights into the heterogeneity of YGL199C expression within yeast populations.
Determining whether an antibody recognizes native protein conformations is critical for applications like immunoprecipitation. Consider these approaches:
Native vs. denatured comparison: Compare antibody binding to native protein (in non-denaturing immunoprecipitation) versus denatured protein (in Western blotting).
Immunoprecipitation validation: Perform immunoprecipitation followed by mass spectrometry to confirm capture of YGL199C and identify any co-precipitating partners.
Structural epitope mapping: For monoclonal antibodies targeting different regions (N-terminus, C-terminus, and M-terminus) , perform epitope mapping to determine the specific amino acid sequences recognized.
Cross-linking experiments: Use chemical cross-linking prior to cell lysis to stabilize protein complexes, then perform immunoprecipitation to identify YGL199C interaction partners in their native context.
The monoclonal antibody combinations available for YGL199C are designed to target specific regions , which may have different accessibility in the native versus denatured protein.
While YGL199C is currently described as a putative uncharacterized protein , studying its interactions can help elucidate its function:
Co-immunoprecipitation: Use YGL199C antibodies to pull down the protein along with its binding partners, followed by mass spectrometry to identify the components of the complex.
Proximity labeling: Fuse YGL199C to a proximity labeling enzyme (BioID or APEX2) to identify proteins in its vicinity in living cells, then use YGL199C antibodies to confirm interactions.
Yeast two-hybrid screening: Complement antibody-based approaches with genetic screens to identify potential interaction partners.
Chromatin immunoprecipitation (ChIP): If YGL199C is suspected to interact with chromatin, ChIP using YGL199C antibodies can identify associated DNA regions.
Super-resolution microscopy: Combine YGL199C antibodies with fluorescently labeled antibodies against suspected interaction partners to visualize co-localization at sub-diffraction resolution.
When designing these experiments, it's important to consider that YGL199C's function remains uncharacterized, so exploratory approaches that don't rely on assumptions about its role may be most informative.
Immunofluorescence in yeast requires specialized protocols due to the cell wall. While not specifically documented for YGL199C, the following protocol can be adapted:
Cell fixation and spheroplasting:
Fix cells with 3.7% formaldehyde for 30 minutes at room temperature
Wash 3× with PBS
Digest cell wall with zymolyase or lyticase in sorbitol buffer (1.2M sorbitol, 0.1M potassium phosphate, pH 7.5) for 20-30 minutes at 30°C
Monitor spheroplasting microscopically
Permeabilization and blocking:
Permeabilize with 0.1% Triton X-100 for 5 minutes
Block with 1% BSA and 0.1% Tween-20 in PBS for 30 minutes
Antibody incubation:
Primary antibody: Start with 1:100 to 1:500 dilution of YGL199C antibody in blocking buffer
Incubate overnight at 4°C
Wash 3× with PBS + 0.1% Tween-20
Secondary antibody: Use appropriate fluorophore-conjugated secondary at 1:1000 dilution
Incubate 1 hour at room temperature in the dark
Wash 3× with PBS + 0.1% Tween-20
Mounting and imaging:
Mount with anti-fade medium containing DAPI
Image using confocal or wide-field fluorescence microscopy
Optimization is essential, as the precise localization pattern of YGL199C is not well documented. Include appropriate controls at each step to validate specificity.
Flow cytometry with yeast requires special considerations. Here's a protocol framework for YGL199C analysis:
Sample preparation:
Staining protocol:
Block with 10% serum from same host as secondary antibody
Incubate with YGL199C primary antibody (start with 1:100 dilution)
Wash 2× with PBS + 0.1% sodium azide
Incubate with fluorophore-conjugated secondary antibody
Wash 2× with PBS + 0.1% sodium azide
Essential controls:
Gating strategy:
Gate on singlet yeast cells using FSC-A vs. FSC-H
Exclude dead cells using viability dye
Analyze YGL199C expression within viable single-cell population
Data analysis considerations:
Report median fluorescence intensity rather than mean, as yeast populations often show non-normal distributions
Quantify the percentage of positive cells relative to appropriate negative controls
All flow cytometry steps should be performed on ice with buffers containing 0.1% sodium azide to prevent internalization of surface antigens .
Research has indicated that YGL199C may be involved in processes related to stationary phase in yeast . Antibodies can help investigate these dynamics:
Temporal expression analysis: Use YGL199C antibodies to track protein expression levels across different growth phases, particularly during transition to stationary phase.
Subcellular localization changes: Combine fractionation techniques with Western blotting using YGL199C antibodies to monitor potential relocalization during stationary phase.
Post-translational modifications: Use phospho-specific antibodies or combine standard YGL199C antibodies with techniques like Phos-tag gels to investigate regulation by phosphorylation during stationary phase.
Protein stability studies: Perform cycloheximide chase experiments and use YGL199C antibodies to assess protein half-life changes during different growth phases.
Stress response correlation: Analyze how YGL199C protein levels (detected by antibodies) correlate with stress responses typical of stationary phase, such as oxidative stress or nutrient limitation.
This approach could provide valuable insights into the function of this uncharacterized protein in yeast cellular responses to stationary phase conditions.
A multi-faceted approach combining antibody-based techniques with other methodologies can help elucidate YGL199C function:
Genetic-proteomic correlation:
Use YGL199C antibodies to quantify protein levels in wild-type and mutant strains
Correlate phenotypic changes in YGL199C deletion or overexpression strains with protein levels in different genetic backgrounds
Systematic interaction mapping:
Structure-function analysis:
Evolutionary conservation study:
Use YGL199C antibodies to test cross-reactivity with homologous proteins in related yeast species
Correlate conservation of antibody epitopes with functional importance
Integration with genomic data:
Compare YGL199C protein levels (detected by antibodies) with transcriptomic data from RNA-seq
Analyze post-transcriptional regulation mechanisms
This integrative approach leverages the specificity of YGL199C antibodies while overcoming their limitations through complementary methodologies.
Based on the available information and general antibody best practices, researchers should:
Validate specificity: Test antibodies on samples from YGL199C deletion strains or through epitope tagging approaches.
Optimize conditions: Perform systematic titration and condition optimization for each application.
Include comprehensive controls: Follow the control recommendations detailed in section 2.1.
Document lot-to-lot variation: Keep detailed records of antibody performance across different lots, as antibody properties can vary.
Consider epitope accessibility: Use antibodies targeting different regions of YGL199C to ensure detection regardless of potential structural occlusion.
Share protocols: Contribute optimized protocols to community resources to advance collective understanding of this uncharacterized protein.